emfizz.com July 25, 2017

Stock'S Earning Overview Ocular Therapeutix, Inc. (OCUL)

17 July 2017, 08:34 | Jan Cross

Other large investors have also recently modified their holdings of the company. State Street Corp raised its stake in shares of Ocular Therapeutix by 21.8% in the fourth quarter. Cantor Fitzgerald analyst E. Piros now expects that the biopharmaceutical company will post earnings per share of ($2.09) for the year, up from their prior forecast of ($2.63). Renaissance Technologies LLC acquired a new stake in Ocular Therapeutix during the fourth quarter valued at approximately $1,214,000. Wellington Management Group LLP boosted its position in shares of Ocular Therapeutix by 35.2% in the first quarter. Parametric Portfolio Associates LLC now owns 30,582 shares of the biopharmaceutical company's stock worth $284,000 after buying an additional 401 shares during the last quarter. Janney Montgomery Scott LLC bought a new stake in shares of Ocular Therapeutix during the first quarter worth about $110,000. Berson & Corrado Investment Advisors LLC now owns 32,805 shares of the biopharmaceutical company's stock worth $304,000 after buying an additional 1,785 shares during the last quarter. The institutional investor owned 87,046 shares of the biopharmaceutical company's stock after buying an additional 17,445 shares during the period.

Research professionals at Morgan Stanley now has a $8 target on Ocular Therapeutix (NASDAQ:OCUL). (NASDAQ:OCUL) has gone stronger by 29.45%. The firm's 50-day moving average is $10.44 and its 200 day moving average is $8.94.

Ocular Therapeutix, Inc. has a one year low of $4.04 and a one year high of $11.91. The company has market cap of $174.77 million.

Ocular Therapeutix (NASDAQ:OCUL) last issued its quarterly earnings data on Friday, May 5th. The biopharmaceutical company reported ($0.58) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.48) by $0.10. The Return on Equity ratio of Ocular Therapeutix, Inc. According to these analysts, the Low Revenue Estimate for Ocular Therapeutix, Inc.is 450 Million and the High Revenue Estimate is 520 Million.

Hornbeck Offshore Services (NYSE:HOS) Closed Significantly Above Its 50 Day Average
Manufacturers Life Insurance The holds 23,438 shares. 61,250 shares were bought by HORNBECK TODD M , worth $199,675. Kennedy Capital Management Inc sold 204,868 shares as Hornbeck Offshore Services Inc (HOS)'s stock declined 45.49%.

Forecasters Watching Two Potential Storms in Atlantic
The National Hurricane Centre (NHC) in Miami said this morning that it has a 50 percent chance of developing in the next two days. Showers and thunderstorms are developing near the center of this system and it looks like further development is possible.

Playing the next round of 'Let's Make A Deal' with the Cubs
A PADRES 7, GIANTS 1: Hector Sanchez and Corey Spangenberg each hit a three-run homer as San Diego won at home. Yet again, the Orioles bullpen came in and did its job after a starter struggled to do the same.

ILLEGAL ACTIVITY WARNING: This news story was first reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this article on another domain, it was stolen and republished in violation of U.S. & global copyright law.

Insider Trades for Ocular Therapeutix, Inc. show that the latest trade was made on 14 Dec 2016 where Sawhney (Amarpreet), the Chief Executive Officer completed a transaction type "Buy" in which 45300 shares were traded at a price of $7.85. Morgan Stanley upgraded the shares of OCUL in report on Thursday, February 18 to "Overweight" rating. However, on July 6, 2017, an article published by Seeking Alpha claimed that Ocular Therapeutix's management had been misleading investors about manufacturing issues. Analysts have a mean recommendation of 2.80 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). At the time of writing, Shares the company recently traded 64.73% away 52-week low and noted price movement -44.11% away from the 52-week high level. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company's stock. Ocular Therapeutix now has a consensus rating of "Hold" and a consensus price target of $21.55.

Several analysts have released their opinion on Ocular Therapeutix, Inc. The Firm is focused on the development and commercialization of therapies for diseases and conditions of the eye using its hydrogel platform technology.

Other News

Trending Now

Host Kamal Haasan defends Tamil Bigg Boss
But, the situation went worse with Prison and Law Affairs Minister, CV Shanmugam's repeated blows to Kamal Haasan's personal life. In fact, he was one of the few actors who spoke about the mismanagement during the 2015 rains which nearly sank Chennai .

Parents accuse R. Kelly of holding their daughters in abusive cult
Police in both IL and Georgia have conducted welfare checks at both properties in the past year that have not brought any charges. You have to ask to go to the bathroom... "Speaking to Buzzfeed , one was quoted as saying: "[Kelly] is a master at mind control.

Donald Trump REFUSING state visit until Theresa May 'FIXES better press coverage'
However no date has yet been set for the visit - which had originally been expected to take place this year. More than 1.8 million people signed a petition to prevent Trump from the honorary state visit.

Egypt attacks: Two German female tourists, five policemen killed
In an alert on its website, the Embassy urged its tourists not to travel alone in Egypt or visit unofficial scenic spots. Rashed made the comments to TV talk-show host Amr Adib on his programme Kol Youm late on Saturday.

Amazon Trademark Filing Puts Target On Blue Apron, Meal Delivery
Most meal kits on Amazon Fresh are now priced between $10 and $24 and include ingredients for at least two servings. It may be some time before we see Amazon-branded meal kits online, but the competition is already feeling the heat.

Thomas Lemar has the right profile for Arsenal, says Robert Pires
Arsenal's pursuit has been strong, especially considering the uncertainty surrounding the future of Alexis Sanchez at the moment. He made 34 appearances last season and was always on the Gunners' radar.

Major cyber attack could trigger losses of £40.5bn, says Lloyd's
What makes it even more challenging is a lack of historical data on which insurers can base their assumptions. NotPetya was significantly less costly - globally, it cost organizations US$850 million.

No Exceptions For Depositing Old Notes: Centre To Chief Justice Of India
Prime Minister Narendra Modi had surprised the nation on November 8 when he declared the old Rs 500 and 1000 notes invalid. A woman said that she was delivering her baby whereas another person said that there was a death in his family.

Afghan forces recapture key district
The report commended Afghanistan's security forces, saying fewer civilians were caught in the crossfire compared to a year ago . Defense Ministry's spokesman, Daulat Waziri, said on Monday that the battle to recapture the district of Naway had been fierce.

Herrera: Morata was very close to joining Manchester United
United insiders believe a bid from Real is imminent as the two clubs prepare to meet on their US tour in Santa Clara on July 23. He started his career at Atletico Madrid and a return back to the city could prove too difficult to turn down.